Cardio Diagnostics Holdings, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
CDIO Nasdaq 2836 cardiodiagnosticsinc.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. (CDIO) Secures Medicare Pricing Approval for Precision Cardiovascular Tests - Dec 18th, 2024 7:03 am
Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests - Dec 16th, 2024 1:31 pm
Cardio Diagnostics Holdings Third Quarter 2024 Earnings: Misses Expectations - Nov 16th, 2024 1:59 pm
Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference - Nov 12th, 2024 1:31 pm
Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests - Oct 1st, 2024 12:31 pm
Potential Catalyst Right Around The Corner? CMS To Announce Preliminary Medicare Payment For Cardio Diagnostics' Heart Disease Tests - Sep 17th, 2024 6:15 pm
Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions - Jul 29th, 2024 12:45 pm
Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois - Jun 27th, 2024 3:17 pm
Cardio Diagnostics Announces It’s Exhibiting at the 2024 Onsite Employee Health Clinics Forum - Jun 25th, 2024 12:31 pm
Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality - Jun 10th, 2024 12:31 pm
Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services’ (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative Tests - May 21st, 2024 12:31 pm
Cardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists’ Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois, That Offers Walk-In Appointments Seven Days a Week - May 13th, 2024 12:31 pm
Cardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD™ Test Could Save Health Insurers Over $113 Million Annually - Apr 29th, 2024 12:31 pm
Exponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in Michigan - Apr 9th, 2024 12:31 pm
Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre - Apr 4th, 2024 12:31 pm
Cardio Diagnostics Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag - Apr 3rd, 2024 11:00 am
Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology’s 73rd Annual Scientific Session - Mar 14th, 2024 12:31 pm
Cardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease - Mar 5th, 2024 1:31 pm
Cardio Diagnostics Holdings, Inc. Expands HeartRisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide Rollout - Feb 15th, 2024 1:46 pm
Cardio Diagnostics Holdings, Inc. Expands Partnership with Family Medicine Specialists to Bring Its Specialty Cardiology Tests to Select Walmart Supercenters - Feb 7th, 2024 1:31 pm